Robert A. Winn

Robert A. Winn

Department of Pulmonary, University of Illinois at Chicago

Affiliated withUniversity of Illinois at ChicagoJesse Brown Veterans Affairs Medical Center

Research Area

Biography

Robert A. Winn has not added Biography.
If you are Robert A. Winn and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
<em>In vitro </em>Methylation Assay to Study Protein Arginine Methylation
Publication title

Cited by 8

2014
The Soft Agar Colony Formation Assay
Publication title

Cited by 525

2014

Other Publications

Article
Year
gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.

Oncogene| PubMed ID: 12386812

2002
2002
2002
2004
2004
2005
A middle-aged woman with recurrent respiratory infections.

Respiration; international review of thoracic diseases| PubMed ID: 16088289

2005
Role of nuclear receptors in lung tumourigenesis.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 16199155

2005
Beta-catenin in the fibroproliferative response to acute lung injury.

American journal of respiratory cell and molecular biology| PubMed ID: 16272459

2006
Inhibited neurogenesis in JNK1-deficient embryonic stem cells.

Molecular and cellular biology| PubMed ID: 16314504

2005
2006
Role of the wnt signaling pathway and lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 17909349

2007
2008
Wnt signaling pathway and lung disease.

Translational research : the journal of laboratory and clinical medicine| PubMed ID: 18355764

2008
2008
The cancer paradigm of severe pulmonary arterial hypertension.

American journal of respiratory and critical care medicine| PubMed ID: 18556624

2008
2009
2008
2008
2009
The role of prostacyclin in lung cancer.

Translational research : the journal of laboratory and clinical medicine| PubMed ID: 20129485

2010
2010
2010
2010
2011
2012
2012
2012
2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 23757356

2013
2013
2013
2011